| abstract |
The present disclosure generally relates to compositions comprising antibodies, e.g., monoclonal antibodies, humanized antibodies, and antibody fragments, that specifically bind to an MS4A4A polypeptide, e.g., mammalian MS4A4A or human MS4A4A, and compositions such as to the use of such compositions in the prophylaxis, risk reduction or treatment of a subject in need thereof. |